Skip to main content

Barcelona Teams to Lead $7M EU Malaria, Diabetes Studies

NEW YORK (GenomeWeb News) - A group of scientists in Spain will lead studies of malaria and diabetes that will focus on ‘omics and bioinformatics with €5 million ($7 million) in funding from the European Commission between 2009 and 2011.
 
The Institute for Research in Biomedicine in Barcelona will coordinate both research projects, which are part of the second call of the EU's Seventh Framework Program.
 
In one project, researchers will seek to understand proteins involved in malaria transmission that may be used to inhibit the disease. Called Mephitis, the project is led by Lluis Ribas de Pouplana, head of the Gene Translation Laboratory at IRB Barcelona. These studies will include two groups in Barcelona, two in India, one in France, one in Italy, one from Portugal, and another from Australia.
 
Ribas de Pouplana said we currently “have enough knowledge about protein synthesis in organisms such as the bacteria E. coli or the yeast Saccharomyces cerevisiae, and we now want to transfer this knowledge base to organisms of medical relevance such as Plasmodium,” which will help scientists to “fight effectively against the parasite.”
 
This study will involve experts from several specialty areas, including genome dynamics, bioinformatics, proteomics, transcriptomics, and Plasmodium biology, IRB said.
 
The second research area funded under the program will involve using bioinformatics to gather information about diabetes and other diseases that are the results of a combination of genetic and environmental factors, IRB said. These studies will be led by Antonio Zorzano, head of the Molecular Medicine Program at IRB Barcelona and a senior professor at the University of Barcelona.
 
This consortium will involve six groups, and will aim to identify the processes that happen in mitochondria that are at the root of insulin resistance, which increases the risk of diabetes and coronary disease, and may be related to hypertension and obesity.
 
Zorzano said in a statement that systems biology “can hold and integrate many data about a single disease and can reveal the existence of gene networks and interactions between proteins that are responsible for the key alterations in a disease."
 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.